Home › Markets › Health Care › DXR

Daxor Corporation (DXR)

DXR trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$10.35
+0.45% on the day
Market cap
$60.4M
Micro cap
Revenue
No annual revenue filed since the period ending 2011-12-31
Net income
No annual revenue filed since the period ending 2011-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerDXR on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000027367
Incorporated inNY

Financials

No annual revenue filed since the period ending 2011-12-31.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42026-01-26
Latest annual report
FORM 10-K
10-K2012-03-28
Latest quarterly / interim
FORM 10-Q
10-Q2011-11-14
Latest current report8-K2026-06-24
Latest proxyDEF 14A2026-06-03

Source: SEC EDGAR submissions feed, 736 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
DRIODarioHealth Corp.$5.54+2.21%$54.3M
GUTSFractyl Health Inc.$4.03-8.73%$53.4M
MBOTMicrobot Medical Inc.$1.02-1.92%$68.5M
SKINSkinHealth Systems Inc.$0.5406+2.97%$70.4M
MDAISpectral AI Inc.$1.56-2.50%$50.2M
LUNGPulmonx Corporation$1.76-2.22%$75.6M
SNWVSANUWAVE Health Inc.$5.61-3.94%$48.3M
TELATELA Bio Inc.$1.06-1.39%$48.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier